Medical affairs: The power behind redefining commercialization
In March 2024, Envision Pharma Group held a Medical Affairs Professional Society (MAPS) Americas roundtable with leaders discussing the role of science in commercialization strategies and the importance of integrating robust scientific understanding into the commercial journey. Envision revisited this vital subject in May when they sought the opinion of other pharmaceutical professionals, taking a deeper dive into the need for a re-evaluation of roles and strategies and ascertaining how medical affairs can take a central role in driving brand strategy.
Read our summary in the blog post below.
Image
Medical affairs: The power behind redefining commercialization
Contributors
- Danie du Plessis, Kyowa Kirin
- Joshua Vecht, Kyowa Kirin
- Dorit Helbig, Ipsen
- Aine Prendergast, Ipsen
- Mark Rees-Saunders, Astellas
- Deborah Braccia, Kyowa Kirin
- Lucie Williams, Ipsen
- Joris van Vugt, Viatris
Facilitator
- John McKenna, Former Global Head Medical Excellence
The pharmaceutical industry is at a crossroads with medical affairs, prompting a re-evaluation of